Healthcare Professionals
Learn more about the latest in technological innovations to ablate, necrotize or coagulate soft tissue in the brain.
Patients & Caregivers
Find out more about minimally invasive brain surgery technology for you or your loved one.
NEUROBLATE® SYSTEM
NeuroBlate® is the only minimally invasive, robotic, laser thermotherapy tool that uses MRI-guided surgical ablation technology designed specifically for use in the brain.
The Minimally Invasive Surgical Choice
NeuroBlate provides precise and maximal brain lesion ablation for patients without the invasiveness of an open neurosurgical procedure. The precise nature of the procedure helps lessen the likelihood of harm to nearby healthy tissue.1
Over 3,000 Procedures
NeuroBlate offers hope and healing to patients suffering from a wide range of neurological lesions, including brain tumors and epileptic foci.
EXCLUSIVE TECHNOLOGIES
NeuroBlate delivers a comprehensive, full solution laser ablation system that includes software, disposables, and hardware.
TruTemp™ Technology
Provides confidence in the accuracy of the ablation zone and added safety assurance.
NeuroBlate Fusion™ Software
Allows neurosurgeons to plan, deliver, and monitor MRI-guided robotic laser thermotherapy.
NeuroBlate Optic™ Laser Probe
The first and only commercially available laser probe with fiber optic controlled cooling.
CLINICAL RESEARCH & TRIALS
Our commitment to clinical research is an essential and integral part of our mission and is demonstrated in our clinical trial work.
Active Clinical Trials
The Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate® System (LAANTERN) Prospective Registry is currently enrolling eligible patients.
LITT Evidence
The cumulative utilization of LITT over time has been steadily increasing for metastatic tumor, primary tumor, and epileptic foci.
FIND A PHYSICIAN
Find a surgeon offering NeuroBlate minimally invasive thermotherapy.
RECENT NEWS
Monteris Medical Announces Publication of First Prospective Multicenter Study of Minimally Invasive Laser Ablation for Drug Resistant Epilepsy
Monteris Medical Announces Publication of First Prospective Multicenter Study of Minimally Invasive Laser Ablation for Drug Resistant Epilepsy PLYMOUTH, Minn. – Nov. 10, 2020 – Monteris Medical announced today the publication of results from a multicenter clinical study with its NeuroBlate® System for the treatment of drug resistant epilepsy have been published in the peer-reviewed […]
Monteris Medical Announces New Category Level I CPT® Code(s) from American Medical Association
Monteris Medical Announces New Category Level I CPT® Code(s) from American Medical Association PLYMOUTH, Minn. – Nov. 2, 2020 – Monteris Medical announced today that the application for two new Category Level I CPT® code(s) for laser interstitial thermal therapy (LITT) of intracranial lesion, with magnetic resonance (MR) imaging guidance has been accepted by the […]
Study Suggests Potential Role for Laser Ablation in Glioblastoma Treatment, Monteris Medical Announces
Researchers at the Washington University School of Medicine in St. Louis, Mo., led by neurosurgeon Dr. Albert H. Kim, found direct evidence in mice that the focal thermal effect of laser interstitial thermal therapy (LITT) opens the blood-brain barrier (BBB) and blood-tumor barrier (BTB).
- Rennert RC, Khan U, Barktek J Jr et al. Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): procedural safety and hospitalization. Neurosurgery. published online: May 11, 2019. (doi: 10.1093/neuros/nyz141)